questionsmedicales.fr
Régions géographiques
Villes
Villes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Pollution de l'air
Santé publique
Maladies environnementales
Diagnostic médical
Épidémiologie
Analyse spatiale
Santé urbaine
Épidémiologie
Accès aux soins
Santé publique
Symptômes
5
Pollution de l'air
Symptômes respiratoires
Qualité de l'eau
Maladies infectieuses
Isolement social
Santé mentale
Prévention
5
Prévention
Pollution de l'air
Santé mentale
Espaces verts
Qualité de l'eau
Santé publique
Traitements
5
Maladies respiratoires
Traitement médical
Chaleur
Urgences médicales
Maladies infectieuses
Traitement médical
Anxiété
Traitement médical
Complications
5
Pollution de l'air
Complications médicales
Isolement social
Santé mentale
Chaleur
Urgences médicales
Qualité de l'eau
Maladies infectieuses
Santé mentale
Complications médicales
Facteurs de risque
5
Pollution de l'air
Facteurs de risque
Chaleur
Facteurs de risque
Maladies infectieuses
Facteurs de risque
Comportements de santé
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Villes : Questions médicales les plus fréquentes",
"headline": "Villes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Villes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-31",
"dateModified": "2025-04-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Villes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Régions géographiques",
"url": "https://questionsmedicales.fr/mesh/D005842",
"about": {
"@type": "MedicalCondition",
"name": "Régions géographiques",
"code": {
"@type": "MedicalCode",
"code": "D005842",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Baltimore",
"alternateName": "Baltimore",
"url": "https://questionsmedicales.fr/mesh/D015142",
"about": {
"@type": "MedicalCondition",
"name": "Baltimore",
"code": {
"@type": "MedicalCode",
"code": "D015142",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pékin",
"alternateName": "Beijing",
"url": "https://questionsmedicales.fr/mesh/D000068476",
"about": {
"@type": "MedicalCondition",
"name": "Pékin",
"code": {
"@type": "MedicalCode",
"code": "D000068476",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.114"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Boston",
"alternateName": "Boston",
"url": "https://questionsmedicales.fr/mesh/D001900",
"about": {
"@type": "MedicalCondition",
"name": "Boston",
"code": {
"@type": "MedicalCode",
"code": "D001900",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.210"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chicago",
"alternateName": "Chicago",
"url": "https://questionsmedicales.fr/mesh/D002641",
"about": {
"@type": "MedicalCondition",
"name": "Chicago",
"code": {
"@type": "MedicalCode",
"code": "D002641",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.305"
}
}
},
{
"@type": "MedicalWebPage",
"name": "District de Columbia",
"alternateName": "District of Columbia",
"url": "https://questionsmedicales.fr/mesh/D004219",
"about": {
"@type": "MedicalCondition",
"name": "District de Columbia",
"code": {
"@type": "MedicalCode",
"code": "D004219",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.429"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Los Angeles",
"alternateName": "Los Angeles",
"url": "https://questionsmedicales.fr/mesh/D015141",
"about": {
"@type": "MedicalCondition",
"name": "Los Angeles",
"code": {
"@type": "MedicalCode",
"code": "D015141",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.565"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nouvelle-Orléans",
"alternateName": "New Orleans",
"url": "https://questionsmedicales.fr/mesh/D055820",
"about": {
"@type": "MedicalCondition",
"name": "Nouvelle-Orléans",
"code": {
"@type": "MedicalCode",
"code": "D055820",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.697"
}
}
},
{
"@type": "MedicalWebPage",
"name": "New York (ville)",
"alternateName": "New York City",
"url": "https://questionsmedicales.fr/mesh/D009519",
"about": {
"@type": "MedicalCondition",
"name": "New York (ville)",
"code": {
"@type": "MedicalCode",
"code": "D009519",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.741"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Philadelphie",
"alternateName": "Philadelphia",
"url": "https://questionsmedicales.fr/mesh/D015143",
"about": {
"@type": "MedicalCondition",
"name": "Philadelphie",
"code": {
"@type": "MedicalCode",
"code": "D015143",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.820"
}
}
},
{
"@type": "MedicalWebPage",
"name": "San Francisco",
"alternateName": "San Francisco",
"url": "https://questionsmedicales.fr/mesh/D012495",
"about": {
"@type": "MedicalCondition",
"name": "San Francisco",
"code": {
"@type": "MedicalCode",
"code": "D012495",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Séoul",
"alternateName": "Seoul",
"url": "https://questionsmedicales.fr/mesh/D066106",
"about": {
"@type": "MedicalCondition",
"name": "Séoul",
"code": {
"@type": "MedicalCode",
"code": "D066106",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.887"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tokyo",
"alternateName": "Tokyo",
"url": "https://questionsmedicales.fr/mesh/D014041",
"about": {
"@type": "MedicalCondition",
"name": "Tokyo",
"code": {
"@type": "MedicalCode",
"code": "D014041",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Villes",
"alternateName": "Cities",
"code": {
"@type": "MedicalCode",
"code": "D002947",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Divya Seth",
"url": "https://questionsmedicales.fr/author/Divya%20Seth",
"affiliation": {
"@type": "Organization",
"name": "Division of Allergy/Immunology, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, 3950 Beaubien, 4th Floor, Pediatric Specialty Building, Detroit, MI 48201, USA. Electronic address: dseth@dmc.org."
}
},
{
"@type": "Person",
"name": "Shweta Saini",
"url": "https://questionsmedicales.fr/author/Shweta%20Saini",
"affiliation": {
"@type": "Organization",
"name": "Division of Hospital Medicine, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA."
}
},
{
"@type": "Person",
"name": "Pavadee Poowuttikul",
"url": "https://questionsmedicales.fr/author/Pavadee%20Poowuttikul",
"affiliation": {
"@type": "Organization",
"name": "Division of Allergy/Immunology, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA."
}
},
{
"@type": "Person",
"name": "Marc Barthelemy",
"url": "https://questionsmedicales.fr/author/Marc%20Barthelemy",
"affiliation": {
"@type": "Organization",
"name": "Université Paris-Saclay, CEA, CNRS, Institut de Physique Théorique, 91191 Gif-sur-Yvette, France."
}
},
{
"@type": "Person",
"name": "Sasha Khomenko",
"url": "https://questionsmedicales.fr/author/Sasha%20Khomenko",
"affiliation": {
"@type": "Organization",
"name": "Institute for Global Health, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Neuropsychology and Movement Disorders.",
"datePublished": "2024-06-17",
"url": "https://questionsmedicales.fr/article/39343477",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ncl.2024.05.008"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cannabinoids in movement disorders.",
"datePublished": "2022-08-24",
"url": "https://questionsmedicales.fr/article/36038457",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2022.08.014"
}
},
{
"@type": "ScholarlyArticle",
"name": "Moving Beyond Movement: Diagnosing Functional Movement Disorder.",
"datePublished": "2023-03-09",
"url": "https://questionsmedicales.fr/article/36893796",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1763505"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impaired Metacognition of Voluntary Movement in Functional Movement Disorder.",
"datePublished": "2023-01-06",
"url": "https://questionsmedicales.fr/article/36606550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mds.29303"
}
},
{
"@type": "ScholarlyArticle",
"name": "Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease.",
"datePublished": "2022-07-05",
"url": "https://questionsmedicales.fr/article/35787539",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/WCO.0000000000001075"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Villes",
"item": "https://questionsmedicales.fr/mesh/D002947"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Villes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Villes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-30",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Villes",
"description": "Comment évaluer l'impact de la pollution urbaine sur la santé ?\nQuels tests sont utilisés pour diagnostiquer les maladies liées aux villes ?\nComment identifier les zones à risque sanitaire en ville ?\nQuels indicateurs de santé sont pertinents en milieu urbain ?\nComment évaluer l'accès aux soins en ville ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Movement+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Villes",
"description": "Quels symptômes sont liés à la pollution de l'air ?\nComment la vie urbaine affecte-t-elle la santé mentale ?\nQuels symptômes sont associés à la chaleur urbaine ?\nQuels signes indiquent une mauvaise qualité de l'eau en ville ?\nQuels symptômes sont liés à l'isolement social en ville ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Movement+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Villes",
"description": "Comment prévenir les maladies liées à la pollution en ville ?\nQuelles mesures peuvent réduire le stress urbain ?\nComment améliorer la qualité de l'eau en milieu urbain ?\nQuelles stratégies aident à prévenir les coups de chaleur ?\nComment favoriser la santé mentale en milieu urbain ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Movement+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Villes",
"description": "Quels traitements sont efficaces contre les maladies respiratoires urbaines ?\nComment traiter les effets de la chaleur extrême en ville ?\nQuels traitements sont disponibles pour le stress urbain ?\nComment traiter les maladies liées à l'eau contaminée ?\nQuels traitements sont recommandés pour l'anxiété urbaine ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Movement+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Villes",
"description": "Quelles complications peuvent survenir à cause de la pollution ?\nQuels risques de santé sont liés à l'isolement social ?\nQuelles complications peuvent résulter de la chaleur extrême ?\nComment la qualité de l'eau affecte-t-elle la santé ?\nQuelles complications sont liées à la vie urbaine ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Movement+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Villes",
"description": "Quels facteurs de risque sont associés à la pollution urbaine ?\nComment le stress urbain influence-t-il la santé ?\nQuels sont les risques liés à la chaleur en milieu urbain ?\nQuels facteurs augmentent le risque de maladies infectieuses en ville ?\nQuels comportements augmentent le risque de problèmes de santé en ville ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Movement+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'impact de la pollution urbaine sur la santé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact se mesure par des études épidémiologiques et des indicateurs de santé."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour diagnostiquer les maladies liées aux villes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de laboratoire, des examens cliniques et des enquêtes de santé sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment identifier les zones à risque sanitaire en ville ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse géospatiale et les données de santé publique aident à identifier ces zones."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de santé sont pertinents en milieu urbain ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les taux de maladies respiratoires, cardiovasculaires et d'obésité sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'accès aux soins en ville ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'accès se mesure par la distance aux établissements de santé et la disponibilité des services."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à la pollution de l'air ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, essoufflement, irritation des yeux et fatigue."
}
},
{
"@type": "Question",
"name": "Comment la vie urbaine affecte-t-elle la santé mentale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, l'anxiété et la dépression sont souvent exacerbés par la vie urbaine."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la chaleur urbaine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent déshydratation, épuisement et coups de chaleur."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une mauvaise qualité de l'eau en ville ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent des maladies gastro-intestinales et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'isolement social en ville ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isolement peut entraîner des symptômes de dépression et d'anxiété."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées à la pollution en ville ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des politiques de réduction de la pollution et des campagnes de sensibilisation sont essentielles."
}
},
{
"@type": "Question",
"name": "Quelles mesures peuvent réduire le stress urbain ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Promouvoir des espaces verts et des activités communautaires aide à réduire le stress."
}
},
{
"@type": "Question",
"name": "Comment améliorer la qualité de l'eau en milieu urbain ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des systèmes de filtration et des contrôles réguliers de la qualité de l'eau sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles stratégies aident à prévenir les coups de chaleur ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éduquer sur l'hydratation et l'ombre, et créer des refuges frais sont des stratégies clés."
}
},
{
"@type": "Question",
"name": "Comment favoriser la santé mentale en milieu urbain ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Encourager le soutien social et l'accès à des services de santé mentale est crucial."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre les maladies respiratoires urbaines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bronchodilatateurs, corticostéroïdes et thérapies respiratoires sont courants."
}
},
{
"@type": "Question",
"name": "Comment traiter les effets de la chaleur extrême en ville ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'hydratation, le repos et, si nécessaire, des soins médicaux."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le stress urbain ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie cognitivo-comportementale et les médicaments peuvent aider à gérer le stress."
}
},
{
"@type": "Question",
"name": "Comment traiter les maladies liées à l'eau contaminée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'hydratation, des antibiotiques et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont recommandés pour l'anxiété urbaine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies psychologiques et les médicaments anxiolytiques sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir à cause de la pollution ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies respiratoires chroniques et des cancers."
}
},
{
"@type": "Question",
"name": "Quels risques de santé sont liés à l'isolement social ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isolement peut entraîner des maladies cardiovasculaires et des troubles mentaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter de la chaleur extrême ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des coups de chaleur, des déshydratations sévères et des décès."
}
},
{
"@type": "Question",
"name": "Comment la qualité de l'eau affecte-t-elle la santé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise qualité de l'eau peut entraîner des infections et des maladies gastro-intestinales."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à la vie urbaine ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'anxiété, la dépression et des maladies chroniques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à la pollution urbaine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'industrialisation, le trafic routier et l'urbanisation rapide."
}
},
{
"@type": "Question",
"name": "Comment le stress urbain influence-t-il la santé ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut aggraver des conditions comme l'hypertension et l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels sont les risques liés à la chaleur en milieu urbain ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des maladies chroniques sont particulièrement à risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de maladies infectieuses en ville ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "La densité de population et l'accès limité à l'eau potable augmentent les risques."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de problèmes de santé en ville ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, la sédentarité et une alimentation déséquilibrée sont des comportements à risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Division of Allergy/Immunology, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, 3950 Beaubien, 4th Floor, Pediatric Specialty Building, Detroit, MI 48201, USA. Electronic address: dseth@dmc.org.
Publications dans "Villes" :
3 publications dans cette catégorie
Affiliations :
Division of Hospital Medicine, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA.
Publications dans "Villes" :
3 publications dans cette catégorie
Affiliations :
Division of Allergy/Immunology, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Université Paris-Saclay, CEA, CNRS, Institut de Physique Théorique, 91191 Gif-sur-Yvette, France.
Centre d'Analyse et de Mathématique Sociales, (CNRS/EHESS) 54, Boulevard Raspail, 75006 Paris, France.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Institute for Global Health, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Institute for Global Health, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Institute for Global Health, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Electronic address: mark.nieuwenhuijsen@isglobal.org.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Health Liveable Cities Lab, Centre for Urban Research, RMIT University, Melbourne, Victoria, Australia. Electronic address: billie.giles-corti@rmit.edu.au.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Melbourne Centre for Cities, University of Melbourne, Melbourne, Victoria, Australia.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Health Liveable Cities Lab, Centre for Urban Research, RMIT University, Melbourne, Victoria, Australia.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Lee Kuan Yew Centre for Innovative Cities, Singapore University of Technology and Design, 8 Somapah Road, #02-302, Building 3 Level 2, Singapore 487372.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Lee Kuan Yew Centre for Innovative Cities, Singapore University of Technology and Design, 8 Somapah Road, #02-302, Building 3 Level 2, Singapore 487372.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Adam Mickiewicz University in Poznań, Faculty of Human Geography and Planning, ul. B. Krygowskiego 10, 61-680 Poznań, Poland.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Adam Mickiewicz University in Poznań, Faculty of Human Geography and Planning, ul. B. Krygowskiego 10, 61-680 Poznań, Poland.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany; Molecular Genetics Laboratory, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico. Electronic address: barquera@shh.mpg.de.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
HLA Laboratory, Central Blood Bank, Hospital de Especialidades, Unidad Médica de Alta Especialidad (UMAE) Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Molecular Genetics Laboratory, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico; Immunogenetics Unit, Técnicas Genéticas Aplicadas a la Clínica (TGAC), Mexico City, Mexico.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Blood Bank, UMAE Hospital de Gineco Obstetricia No. 4 "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Molecular Immunogenetics Laboratory, Instituto Nacional de Pediatría (INP), Mexico City, Mexico.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Histocompatibility Laboratory, Central Blood Bank, Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Publications dans "Villes" :
Neuropsychology is important in differential diagnosis, treatment planning, surgical work-up, and support of patients with movement disorders and their families. The cognitive profiles of several move...
On the basis of both scientific progress and popular lore, there is growing optimism in the therapeutic potential of cannabis (marijuana) and cannabinoid-based chemicals for movement disorders. There ...
In recognition of the high interest and controversial nature of this subject, the meeting committee of the International Parkinson and Movement Disorders Society arranged for a talk on cannabis at the...
The endocannabinoid system is strongly tied to motor function and dysfunction, with basic research suggesting several promising therapeutic targets related to cannabinoids for movement disorders. Clin...
Further research is greatly needed to better understand the actual clinical benefits and long-term side effects of medical cannabis products for movement disorders indications and populations....
Functional movement disorder (FMD) is a complex neuropsychiatric syndrome, encompassing abnormal movements and weakness, and is a common cause of potentially disabling neurological symptoms. It is vit...
Motor symptoms in functional movement disorders (FMDs) are experienced as involuntary but share characteristics of voluntary action. Clinical and experimental evidence indicate alterations in monitori...
The objective of this study was to test the prediction that FMDs are associated with a reduced ability to make accurate (metacognitive) judgments about self-performed movements....
We compared 24 patients with FMD (including functional gait disturbance, functional tremor, and functional tics) with 24 age- and sex-matched healthy control subjects in a novel visuomotor-metacogniti...
Patients and control subjects showed comparable motor performance, response accuracy, and use of the confidence scale. However, visuomotor sensitivity in the trajectory judgment was reduced in patient...
Patients with FMD exhibited deficits both when making visuomotor decisions about their own movements and in the metacognitive evaluation of these decisions. Reduced metacognitive insight into voluntar...
The purpose of this review is to outline the impact of the COVID-19 pandemic on movement disorder holistic care, particularly in the care of people with Parkinson disease (PWP)....
As the pandemic unfolds, a flurry of literature was published regarding the impact of COVID-19 on people with Parkinson disease including the direct impact of infection, availability of ambulatory car...
COVID-19 has impacted the care of PWP in numerous ways. Recognizing infection in PWP poses challenges. Specific long-term complications, including emerging reports of long COVID syndrome is a growing ...
Drug-induced movement disorders (DIMDs) are most commonly associated with typical and atypical antipsychotics. However, other drugs such as antidepressants, antihistamines, antiepileptics, antiarrhyth...
Post-stroke movement disorders (PSMD) encompass a wide array of presentations, which vary in mode of onset, phenomenology, response to treatment, and natural history. There are no evidence-based guide...
To survey current opinions and practices on the diagnosis and treatment of PSMD....
A survey was developed by the PSMD Study Group, commissioned by the International Parkinson's and Movement Disorders Society (MDS). The survey, distributed to all members, yielded a total of 529 respo...
Parkinsonism (68%), hemiballismus/hemichorea (61%), tremor (58%), and dystonia (54%) were by far the most commonly endorsed presentation of PSMD, although this varied by region. Basal ganglia stroke (...
Regionally varying opinions and practices on PSMD highlight gaps in (and mistranslation of) epidemiologic and therapeutic knowledge. Multicenter registries and prospective community-based studies are ...
The relationship between antiseizure drugs and movement disorders is complex and not adequately reviewed so far. Antiseizure drugs as a treatment for tremor and other entities such as myoclonus and re...
Hereditary or familial spastic paraplegias (SPG) comprise a group of genetically and phenotypically heterogeneous diseases characterized by progressive degeneration of the corticospinal tracts. The co...
To summarize the clinical descriptions of SPG that manifest with movement disorders or ataxias to assist the clinician in the task of diagnosing these diseases....
We conducted a narrative review of the literature, including case reports, case series, review articles and observational studies published in English until December 2022....
Juvenile or early-onset parkinsonism with variable levodopa-responsiveness have been reported, mainly in SPG7 and SPG11. Dystonia can be observed in patients with SPG7, SPG11, SPG22, SPG26, SPG35, SPG...
Patients with SPG may present with different forms of movement disorders such as parkinsonism, dystonia, tremor, myoclonus and ataxia. The specific movement disorder in the clinical manifestation of a...
Peripherally-induced movement disorders (PIMD) should be considered when involuntary or abnormal movements emerge shortly after an injury to a body part. A close topographic and temporal association b...
A comprehensive PubMed search through a broad range of keywords and combinations was performed in February 2023 to identify relevant articles for this narrative review....
The spectrum of the phenomenology of PIMD is broad and it encompasses both hyperkinetic and hypokinetic movements. Hemifacial spasm is probably the most common PIMD. Others include dystonia, tremor, p...
There is considerable heterogeneity among PIMD in terms of severity and nature of injury, natural course, association with pain, and response to treatment. As some patients may have co-existing functi...